Tag: Prices

Value-based contracts — big talk, big deal, or real deal?

Pharmaceutical companies guaranteeing results and paying for failures? Payers paying more if a cancer patient has a shorter lifespan on a specific drug? Pharma guaranteeing the control of cholesterol? A few years ago, these seemed as unlikely as a biosimilar version of a blockbuster biologic. Now value-based contracting (VBC) seems to be the hottest topic in payer-pharmaceutical company relationships.l?

Read more